Wells Fargo’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,784
Closed -$14.4K 7405
2023
Q1
$14.4K Buy
7,784
+7,466
+2,348% +$13.8K ﹤0.01% 5423
2022
Q4
$353 Sell
318
-84
-21% -$93 ﹤0.01% 6152
2022
Q3
$1K Sell
402
-392
-49% -$975 ﹤0.01% 6216
2022
Q2
$2K Sell
794
-57,702
-99% -$145K ﹤0.01% 6129
2022
Q1
$397K Sell
58,496
-8,999
-13% -$61.1K ﹤0.01% 4299
2021
Q4
$564K Sell
67,495
-124,231
-65% -$1.04M ﹤0.01% 4277
2021
Q3
$1.42M Buy
191,726
+46,815
+32% +$348K ﹤0.01% 3741
2021
Q2
$985K Sell
144,911
-98,043
-40% -$666K ﹤0.01% 3987
2021
Q1
$2.5M Buy
242,954
+130,366
+116% +$1.34M ﹤0.01% 3308
2020
Q4
$788K Buy
112,588
+20,238
+22% +$142K ﹤0.01% 4132
2020
Q3
$753K Buy
92,350
+8,910
+11% +$72.7K ﹤0.01% 3975
2020
Q2
$576K Buy
83,440
+9,409
+13% +$65K ﹤0.01% 4111
2020
Q1
$351K Buy
74,031
+17,911
+32% +$84.9K ﹤0.01% 4166
2019
Q4
$490K Buy
56,120
+11,101
+25% +$96.9K ﹤0.01% 4289
2019
Q3
$150K Buy
45,019
+6,163
+16% +$20.5K ﹤0.01% 4923
2019
Q2
$191K Sell
38,856
-567
-1% -$2.79K ﹤0.01% 4818
2019
Q1
$244K Sell
39,423
-7,759
-16% -$48K ﹤0.01% 4655
2018
Q4
$158K Buy
47,182
+8,568
+22% +$28.7K ﹤0.01% 4864
2018
Q3
$251K Sell
38,614
-110
-0.3% -$715 ﹤0.01% 4714
2018
Q2
$297K Buy
38,724
+1,128
+3% +$8.65K ﹤0.01% 4666
2018
Q1
$840K Sell
37,596
-4,312
-10% -$96.3K ﹤0.01% 3970
2017
Q4
$534K Buy
41,908
+21,127
+102% +$269K ﹤0.01% 4249
2017
Q3
$324K Sell
20,781
-189
-0.9% -$2.95K ﹤0.01% 4489
2017
Q2
$294K Buy
20,970
+17,330
+476% +$243K ﹤0.01% 4411
2017
Q1
$80K Buy
+3,640
New +$80K ﹤0.01% 5030